Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05389332
Other study ID # 132206
Secondary ID Pro2022000533
Status Recruiting
Phase N/A
First received
Last updated
Start date April 15, 2025
Est. completion date April 15, 2026

Study information

Verified date January 2024
Source Rutgers, The State University of New Jersey
Contact Zhaomeng Niu, PhD
Phone 509-339-3076
Email zhaomeng.niu@rutgers.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Hypothesis: More than 80% of the participants (n=40) will complete the intervention at three month (intervention completion) and the six month follow-up (retention rate as feasibility). More than 70% of the participants will report high overall study satisfaction (acceptability) with the intervention and study. This pre-pilot will inform intervention and procedural refinements for the pilot. Hypothesis: Participants who receive the intervention (n=57) will report more skin cancer-related preventive behaviors (e.g., mean of summed score of sun protection behaviors such as use of sunscreen, etc.) at three month and six month follow-up compared to those in the control condition (n=57, who will receive general information about physical activity and nutrition).


Description:

Aim 1: The investigator will conduct individual interviews among key stakeholders such as health care providers and community leaders to plan a mobile skin cancer intervention among Hispanics. Data will be collected from individual interviews (n=10-12) among key stakeholders and triangulated with data from a funded pilot grant (focus groups and surveys with Hispanic community members) to gather information regarding Hispanics perceptions and behaviors related to skin cancer and suggestions for a WhatsApp intervention. Aim 2: Employing a user-centered approach to develop a WhatsApp intervention to promote skin cancer risk-reduction behaviors among Hispanics and encourage engagement in the intervention. Use an iterative qualitative (focus groups with Hispanics, n=32; individual interviews with key stakeholders e.g., health care providers and community leaders, n=10-12) process to incorporate input from Hispanics and relevant stakeholders to develop a mobile WhatsApp intervention that is theory- and culturally-guided. Aim 3: The investigators will evaluate the feasibility and acceptability of this mobile intervention in a single-arm pre-, post-test pilot study among at-risk Hispanics. Aim 4: Refine the intervention and conduct a pilot RCT (n = 114) using this mobile program among Hispanics at risk for skin cancer and assess the preliminary effects of the mobile intervention at 3-month (intervention completion) and 6-month follow-ups.


Recruitment information / eligibility

Status Recruiting
Enrollment 114
Est. completion date April 15, 2026
Est. primary completion date April 15, 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria: - Self-report as Hispanics - 18 years or older - No personal history of skin cancer - Report more than one skin cancer risk factor - Do not engage in sufficient sun protection behaviors - Have not conducted a SSE in the past three months - Own a smartphone and will be willing to use WhatsApp Exclusion Criteria: - Currently being treated for melanoma or nonmelanoma skin cancer

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Hispanics Skin Cancer intervention
With the insights from the community, the investigators will then develop the mobile intervention targeting Hispanics at risk for skin cancer to promote sun protection and SSE and get feedback to optimize the intervention. After the random allocation participants will receive instructions on how to use WhatsApp and then the intervention. They will receive WhatsApp messages about skin cancer for three months with optimal frequencies determined by prior aims and complete a post-intervention survey which contains the same questions in the pre-survey. The pilot RCT will be conducted around the spring/summer of Year four of the R00 when UVR is generally the highest in the US. The participants will be contacted at six months after the baseline survey to complete another survey similar to the post-intervention survey.
Control group: physical activity and nutrition for Hispanics
Content will be developed from established websites such as CDC's Division of Nutrition, Physical Activity and Obesity. We selected these topics because they are also of concern among Hispanics and provide an unrelated attention control.

Locations

Country Name City State
United States Rutgers Cancer Institute of New Jersey New Brunswick New Jersey

Sponsors (1)

Lead Sponsor Collaborator
Rutgers, The State University of New Jersey

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Sun protection behavior by self-report Mean score of use sunscreen with an SPF 30 or higher, seek shade, wear protective clothing, wear wide-brimmed hat, wear sunglasses The change is being assessed at baseline, three month and six month follow-up intervals
Secondary Seek shade behavior by self-report Seek shaded areas The change is being assessed at baseline, three month and six month follow-up intervals
Secondary Wear protective clothing behavior by self-report Wear protective clothing The change is being assessed at baseline, three month and six month follow-up intervals
Secondary Wear wide-brimmed hat behavior by self-report Waer a wide brim hat The change is being assessed at baseline, three month and six month follow-up intervals
Secondary Wear sunglasses behavior by self-report Wear sunglasses The change is being assessed at baseline, three month and six month follow-up intervals
Secondary Skin self-examination Skin examination by oneself Changes at baseline, three month and six month follow-up intervals
Secondary Skin examination by a health care professional skin examination by a health care professional Changes at baseline, three month and six month follow-up intervals
See also
  Status Clinical Trial Phase
Withdrawn NCT03282188 - REO13 Melanoma With of Without GM-CSF Phase 1/Phase 2
Recruiting NCT05179824 - Tempus Priority Study: A Pan-tumor Observational Study
Not yet recruiting NCT04968704 - Computer Modelling to Plan Surgical Reconstruction
Recruiting NCT03301493 - Genomic Testing and Resulting Medical Decisions
Terminated NCT04337931 - A Study to Evaluate Sotigalimab (APX005M) in Subjects With Unresectable or Metastatic Melanoma Phase 2
Withdrawn NCT04127318 - Low-moderate Intensity Pedaling During Immunotherapy Administration N/A
Completed NCT04059588 - A Study Investigating the Safety and Tolerability of an Immune Treatment in Cancer Patients With Lesions to the Skin Phase 1
Recruiting NCT03452774 - SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Terminated NCT00278018 - Peritumoral Injection of Immature Dendritic Cells to Irradiated Skin Metastases of Solid Tumors Phase 1/Phase 2
Completed NCT00859768 - The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients N/A